HCW Biologics (HCWB) Retained Earnings (2021 - 2025)
HCW Biologics' (HCWB) quarterly Retained Earnings came in at -$108.5 million in Q4 2025, down 7.92% YoY from -$117.8 million in Q4 2024, and down 201.3% on a QoQ basis from $107.1 million in Q3 2025.
HCW Biologics (HCWB) Retained Earnings (2021 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 5 years of Retained Earnings data on file, last reported at -$108.5 million in Q4 2025.
- Quarterly Retained Earnings fell 7.92% year-over-year to -$108.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$108.5 million (down 7.92% YoY) and the FY2025 annual result came in at -$108.5 million, down 7.92% from the prior year.
- Retained Earnings fell to -$108.5 million in Q4 2025, from $107.1 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $107.1 million in Q3 2025 to a low of -$108.5 million in Q4 2025.
- A 5-year average of $12.4 million and a median of $81.8 million in 2021 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings soared 454.42% — and 2024, when it slumped 219.72%.
- Tracing HCWB's Retained Earnings over 5 years: stood at $81.8 million in 2021, then climbed by 1.39% to $83.0 million in 2022, then gained by 1.24% to $84.0 million in 2023, then tumbled by 219.72% to -$100.6 million in 2024, then retreated by 7.92% to -$108.5 million in 2025.
- The last three Retained Earnings figures came in at -$108.5 million (Q4 2025), $107.1 million (Q3 2025), and $104.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | HCW Biologics | 2.86 Mn | 2.11 Mn | -93,887.00 | -110.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -108.52 Mn |
| Sep 30, 2025 | 107.13 Mn |
| Jun 30, 2025 | 104.63 Mn |
| Mar 31, 2025 | -102.75 Mn |
| Dec 31, 2024 | -100.56 Mn |
| Sep 30, 2024 | -97.18 Mn |
| Jun 30, 2024 | -93.28 Mn |
| Mar 31, 2024 | 86.74 Mn |
| Dec 31, 2023 | 83.99 Mn |
| Sep 30, 2023 | 83.72 Mn |
| Jun 30, 2023 | 83.50 Mn |
| Mar 31, 2023 | -50.61 Mn |
| Dec 31, 2022 | 82.96 Mn |
| Sep 30, 2022 | -40.12 Mn |
| Jun 30, 2022 | 82.37 Mn |
| Mar 31, 2022 | 82.09 Mn |
| Dec 31, 2021 | 81.83 Mn |
| Sep 30, 2021 | -27.46 Mn |
| Jun 30, 2021 | -23.24 Mn |